Lexaria Bioscience Corp. - COM NEW (LEXX)

CUSIP: 52886N406

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM NEW
Total 13F shares
1,771,138
Share change
+878,857
Total reported value
$1,770,635
Price per share
$1.00
Number of holders
14
Value change
+$883,097
Number of buys
6
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q3 2023

As of 30 Sep 2023, Lexaria Bioscience Corp. - COM NEW (LEXX) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,771,138 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), 1832 Asset Management L.P., WELLS FARGO & COMPANY/MN, and OSAIC HOLDINGS, INC.. This page lists 14 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.